Human electrophysiological correlates of learned irrelevance: Effects of the muscarinic M1 antagonist biperiden

International Journal of Neuropsychopharmacology

Volumn 15, Issue 10, 2012, Pages 1375-1385

  Klinkenberg, Inge ^a   Blokland, Arjan ^a   Riedel, Wim ^a   Sambeth, Anke ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Acetylcholine; attention; cognition; even related potentials; schizophrenia

Indexed keywords

BIPERIDEN; MUSCARINIC M1 RECEPTOR ANTAGONIST; PLACEBO;

ADULT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; INFORMATION PROCESSING; LATENT PERIOD; MALE; NEUROPHARMACOLOGY; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; REACTION TIME;

ADULT; BIPERIDEN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGICAL PHENOMENA; EVOKED POTENTIALS; FEMALE; HUMANS; LEARNING; MALE; MUSCARINIC ANTAGONISTS; PHOTIC STIMULATION; REACTION TIME; RECEPTOR, MUSCARINIC M1; YOUNG ADULT;

EID: 84867243791     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001647     Document Type: Article

References (72)

1. Allen MT, Chelius L, Masand V, Gluck MA, et al. (2002). A comparison of latent inhibition and learned irrelevance pre-exposure effects in rabbit and human eyeblink conditioning. Integrative Physiological and Behavioral Science 37, 188-214.
2. Baker AG (1976). Learned irrelevance and learned helplessness : rats learn that stimuli, reinforcers, and responses are uncorrelated. Journal of Experimental Psychology: Animal Behavior Processes 2, 130-141.
3. Barak S (2009). Modeling cholinergic aspects of schizophrenia : focus on the antimuscarinic syndrome. Behavioural Brain Research 204, 335-351.
4. Barcelo F, Knight RT (2007). An information-theoretical approach to contextual processing in the human brain : evidence from prefrontal lesions. Cerebral Cortex 17, i51-i60.
5. Bennett IJ, Golob EJ, Starr A (2004). Age-related differences in auditory event-related potentials during a cued attention task. Clinical Neurophysiology 115, 2602-2615.
6. Bolden C, Cusack B, Richelson E (1992). Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. Journal of Pharmacology and Experimental Therapeutics 260, 576-580.
7. Bond A, Lader M (1974). The use of analogue scales in rating subjective feelings. British Journal of Medical Psychology 80, 1-46.
8. Brooks JM, Sarter M, Bruno JP (2011). Transient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophrenia. Neuropsychopharmacology 36, 2477-2487.
9. Crook JM, Tomaskovic-Crook E, Copolov DL, Dean B (2000). Decreased muscarinic receptor binding in subjects with schizophrenia : a study of the human hippocampal formation. Biological Psychiatry 48, 381-388.
10. Crook JM, Tomaskovic-Crook E, Copolov DL, Dean B (2001). Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia : a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. American Journal of Psychiatry 158, 918-925.
11. Dean B, Crook JM, Opeskin K, Hill C et al. (1996). The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia. Molecular Psychiatry 1, 54-58.
12. Dean B, Crook JM, Pavey G, Opeskin K, et al. (2000). Muscarinic1 and 2 receptor mRNA in the human caudateputamen: no change in m1 mRNA in schizophrenia. Molecular Psychiatry 5, 203-207.
13. Deng C, Huang X (2005). Decreased density of muscarinic receptors in the superior temporal gyrus in schizophrenia. Journal of Neuroscience Research 81, 883-890.
14. Donchin E (1981). Surprise! Surprise? Psychophysiology 18, 493-513.
15. Duncan-Johnson CC, Donchin E (1977). On quantifying surprise : the variation of event-related potentials with subjective probability. Psychophysiology 14, 456-467.
16. Duncan-Johnson CC, Donchin E (1980). The relation of P300 latency to reaction time as a function of expectancy. Progress in Brain Research 54, 717-722.
17. Fjell AM, Walhovd KB (2004). Life-span changes in P3a. Psychophysiology 41, 575-583.
18. Fleischhacker WW, Barnas C, Gunther V, Meise U, et al. (1987). Mood-altering effects of biperiden in healthy volunteers. Journal of Affective Disorders 12, 153-157.
19. Fogelson N, Wang X, Lewis JB, Kishiyama MM, et al. (2008). Multimodal effects of local context on target detection : evidence from P3b. Journal of Cognitive Neuroscience 21, 1680-1692.
20. Gal G, Mendlovic S, Bloch Y, Beitler G, et al. (2005). Learned irrelevance is disrupted in first-episode but not chronic schizophrenia patients. Behavioural Brain Research 159, 267-275.
21. Garca-Larrea L, Lukaszewicz A, Mauguiere F (1992). Revisiting the oddball paradigm. Non-target vs. neutral stimuli and the evaluation of ERP attentional effects. Neuropsychologia 30, 723-741.
22. Garcia-Rill E, Biedermann JA, Chambers T, Skinner RD, et al. (1995). Mesopontine neurons in schizophrenia. Neuroscience 66, 321-335.
23. Gluck MA, Myers CE (1993). Hippocampal mediation of stimulus presentation : a computational theory. Hippocampus 3, 491-516.
24. Golob EJ, Pratt H, Starr A (2002). Preparatory slow potentials and event-related potentials in an auditory cued attention task. Clinical Neurophysiology 113, 1544-1557.
25. Guterman Y, Josiassen RC, Bashore TE, Johnson M, et al. (1996). Latent inhibition effects reflected in event-related brain potentials in healthy controls and schizophrenics. Schizophrenia Research 20, 315-326.
26. Guthrie SK, Manzey L, Scott D, Giordani B, et al. (2000). Comparison of central and peripheral pharmacologic effects of biperiden and trihexyphenidyl in human volunteers. Journal of Clinical Psychopharmacology 20, 77-83.
27. Haider M, Spong P, Lindsley DB (1964). Attention, vigilance, and cortical evoked-potentials in humans. Science 145, 180-182.
28. Hollman M, Muller-Peltzer H, Greger G, Brode E, et al. (1987). Pharmacokinetic-dynamic study on different oral biperiden formulations in volunteers. Pharmacopsychiatry 20, 72-77.
29. Hollmann M, Brode E, Greger G, Muller-Peltzer H, et al. (1984). Biperiden effects and plasma levels in volunteers. European Journal of Clinical Pharmacology 27, 619-621.
30. Jasper H (1958). The ten-twenty electrode system of the international federation. Electroencephalography and Clinical Neurophysiology 10, 371-375.
31. Jerger K, Biggins C, Fein G (1992). P50 suppression is not affected by attentional manipulations. Biological Psychiatry 31, 365-377.
32. Katayama S, Ishizaki F, Yamamura Y, Khoriyama T, et al. (1990). Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain. Research Communications in Chemical Pathology and Pharmacology 69, 261-270.
33. Kathmann N, Von Recum S, Haag C, Engel RR (2000). Electrophysiological evidence for reduced latent inhibition in schizophrenic patients. Schizophrenia Research 45, 103-114.
34. Kho KH, Verkes RJ, Eling P, Zwarts MJ, et al. (2003). P50 gating is not affected by selective attention. Journal of Psychophysiology 17, 23-29.
35. Kutas M, McCarthy G, Donchin E (1977). Augmenting mental chronometry : the P300 as a measure of stimulus evaluation time. Science 197, 792-795.
36. Larrabee GJ, Kane RL (1986). Reversed digit repetition involves visual and verbal processes. International Journal of Neuroscience 30, 11-15.
37. Lubow RE (2005). The visual search analogue of latent inhibition : implications for theories of irrelevant stimulus processing in normal and schizophrenic groups. Psychonomic Bulletin and Review 12, 224-243.
38. Mackintosh N (1973). Stimulus selection : learning to ignore stimuli that predict no change in reinforcement. In : Hinde R, Stevenson-Hinde J (Eds), Constraints on Learning : Limitations and Predispositions (pp. 75-96). New York: Academic Press.
39. Mangun GR, Hillyard SA (1991). Modulations of sensoryevoked brain potentials indicate changes in perceptual processes during visual-spatial priming. Journal of Experimental Psychology : Human Perception and Performance 17, 1057-1074.
40. McNair DM, Lorr M, Droppleman LF (1971). Manual for the Profile of Mood States. San Diego, California : Educational and Industrial Testing Service.
41. Mintzer J, Burns A (2000). Anticholinergic side-effects of drugs in elderly people. Journal of the Royal Society of Medicine 93, 457-462.
42. Naatanen R (1990). The role of attention in auditory information processing as revealed by event-related potentials and other brain measures of cognitive function. Behavioral and Brain Sciences 13, 201-288.
43. Naatanen R, Sams M, Alho K, Paavilainen P, et al. (1988). Frequency and location specificity of the human vertex N1 wave. Electroencephalography and Clinical Neurophysiology 69, 523-531.
44. Newell KA, Zavitsanou K, Kum Jew S, Huang X (2007). Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31, 225-233.
45. Ogino S, Miyamoto S, Tenjin T, Kitajima R, et al. (2011). Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35, 78-83.
46. Orosz A, Feldon J, Gal G, Simon A, Cattapan-Ludewig K (2007). Repeated measurements of learned irrelevance by a novel within-subject paradigm in humans. Behavioural Brain Research 180, 1-3.
47. Orosz A, Feldon J, Gal G, Simon A, Cattapan-Ludewig K (2008). Deficient associative learning in drug-naive first-episode schizophrenia: results obtained using a new visual within-subjects learned irrelevance paradigm. Behavioural Brain Research 193, 101-107.
48. Orosz AT, Feldon J, Simon AE, Hilti LM, et al. (2011). Learned irrelevance and associative learning is attenuated in individuals at risk for psychosis but not in asymptomatic first-degree relatives of schizophrenia patients : translational state markers of psychosis? Schizophrenia Bulletin 37, 973-981.
49. Owen F, Cross AJ, Crow TJ, Lofthouse R, et al. (1981). Neurotransmitter receptors in brain in schizophrenia. Acta Psychiatrica Scandinavica (Suppl.) 291, 20-28.
50. Pekkonen E, Jaaskelainen IP, Kaakkola S, Ahveninen J (2005). Cholinergic modulation of preattentive auditory processing in aging. NeuroImage 27, 387-392.
51. Peters NL (1989). Snipping the thread of life. Antimuscarinic side-effects of medications in the elderly. Archives of Internal Medicine 149, 2414-2420.
52. Polich J, Criado JR (2006). Neuropsychology and neuropharmacology of P3a and P3b. International Journal of Psychophysiology 60, 172-185.
53. Rockstroh B, Muller M, Heinz A, Wagner M, et al. (1996). Modulation of auditory responses during oddball tasks. Biological Psychology 43, 41-55.
54. Sarter M, Lustig C, Taylor SF (2010). Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments. Neuropharmacology. Published online: 13 December 2010. doi:10.1016/j. neuropharm.2010.12.001.
55. Scarr E, Cowie TF, Kanellakis S, Sundram S, et al. (2008). Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia. Molecular Psychiatry 14, 1017-1023.
56. Scarr E, Sundram S, Keriakous D, Dean B (2007). Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia. Biological Psychiatry 61, 1161-1170.
57. Schmajuk N (2005). Brain-behaviour relationships in latent inhibition : a computational model. Neuroscience and Biobehavioral Reviews 29, 1001-1020.
58. Semlitsch HV, Anderer P, Schuster P, Presslich O (1986). Asolution for reliable andvalid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 23, 695-703.
59. Sutton S, Braren M, Zubin J (1965). Evoked-potential correlates of stimulus uncertainty. Science 150, 1187-1188.
60. Sutton S, Tueting P, Zubin J, John ER (1967). Information delivery and the sensory evoked potential. Science 155, 1436-1439.
61. Suwazono S, Machado L, Knight RT (2000). Predictive value of novel stimuli modifies visual event-related potentials and behavior. Clinical Neurophysiology 111, 29-39.
62. Tandon R, Shipley JE, Greden JF, Mann NA, et al. (1991). Muscarinic cholinergic hyperactivity in schizophrenia : relationship to positive and negative symptoms. Schizophrenia Research 4, 23-30.
63. Tandon R, Taylor SF, DeQuardo JR, Eiser A, et al. (1999). The cholinergic system in schizophrenia reconsidered: anticholinergic modulation of sleep and symptom profiles. Neuropsychopharmacology 21, S189-S202.
64. Tune L, Carr S, Hoag E, Cooper T (1992). Anticholinergic effects of drugs commonly prescribed for the elderly : potential means for assessing risk of delirium. American Journal of Psychiatry 149, 1393-1394.
65. Verleger R (1997). On the utility of P3 latency as an index of mental chronometry. Psychophysiology 34, 131-156.
66. Watanabe S, Nishikawa T, Takashima M, Toru M (1983). Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics. Life Sciences 33, 2187-2196.
67. Weiner I (2003). The "two-headed" latent inhibition model of schizophrenia : modeling positive and negative symptoms and their treatment. Psychopharmacology 169, 257-297.
68. Wezenberg E, Verkes RJ, Sabbe BG, Ruigt GS, et al. (2005). Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects. Psychopharmacology 181, 582-594.
69. White PM, Yee CM (1997). Effects of attentional and stressor manipulations on the P50 gating response. Psychophysiology 34, 703-711.
70. Yokogawa K, Nakashima E, Ichimura F (1990). Effect of fat tissue volume on the distribution kinetics of biperiden as a function of age in rats. Drug Metabolism and Disposition 18, 258-263.
71. Young AMJ, Kumari V, Mehtrotra R, Hemsley DR, et al. (2005). Disruption of learned irrelevance in acute schizophrenia in a novel continuous within-subject paradigm suitable for fMRI. Behavioural Brain Research 156, 277-288.
72. Zavitsanou K, Katsifis A, Mattner F, Huang X (2004). Investigation of M1/M4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Neuropsychopharmacology 29, 619-625.